Tavistock Adult Depression Study (TADS): a randomised controlled trial of psychoanalytic psychotherapy for treatment-resistant/treatment-refractory forms of depression
| Autor: | Jo-anne Carlyle, Peter Fonagy, Susan McPherson, Felicitas Rost, Rachel Thomas, David Taylor |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
Adult
Research design medicine.medical_specialty Psychotherapist lcsh:RC435-571 Cost-Benefit Analysis law.invention Depressive Disorder Treatment-Resistant Study Protocol Quality of life (healthcare) Clinical Protocols Randomized controlled trial law lcsh:Psychiatry medicine History of depression Humans Bipolar disorder Psychiatry Depression (differential diagnoses) Depressive Disorder Major Primary Health Care business.industry medicine.disease Mental health Psychoanalytic Therapy Psychiatry and Mental health Treatment Outcome Research Design Major depressive disorder business Follow-Up Studies |
| Zdroj: | BMC Psychiatry BMC Psychiatry, Vol 12, Iss 1, p 60 (2012) |
| ISSN: | 1471-244X |
| DOI: | 10.1186/1471-244x-12-60 |
| Popis: | Background Long-term forms of depression represent a significant mental health problem for which there is a lack of effective evidence-based treatment. This study aims to produce findings about the effectiveness of psychoanalytic psychotherapy in patients with treatment-resistant/treatment-refractory depression and to deepen the understanding of this complex form of depression. Methods/Design INDEX GROUP: Patients with treatment resistant/treatment refractory depression. DEFINITION & INCLUSION CRITERIA: Current major depressive disorder, 2 years history of depression, a minimum of two failed treatment attempts, ≥14 on the HRSD or ≥21 on the BDI-II, plus complex personality and/or psycho-social difficulties. EXCLUSION CRITERIA: Moderate or severe learning disability, psychotic illness, bipolar disorder, substance dependency or receipt of test intervention in the previous two years. DESIGN: Pragmatic, randomised controlled trial with qualitative and clinical components. TEST INTERVENTION: 18 months of weekly psychoanalytic psychotherapy, manualised and fidelity-assessed using the Psychotherapy Process Q-Sort. CONTROL CONDITION: Treatment as usual, managed by the referring practitioner. RECRUITMENT: GP referrals from primary care. RCT MAIN OUTCOME: HRSD (with ≤14 as remission). SECONDARY OUTCOMES: depression severity (BDI-II), degree of co-morbid disorders Axis-I and Axis-II (SCID-I and SCID-II-PQ), quality of life and functioning (GAF, CORE, Q-les-Q), object relations (PROQ2a), Cost-effectiveness analysis (CSRI and GP medical records). FOLLOW-UP: 2 years. Plus: a). Qualitative study of participants’ and therapists’ problem formulation, experience of treatment and of participation in trial. (b) Narrative data from semi-structured pre/post psychodynamic interviews to produce prototypes of responders and non-responders. (c) Clinical case-studies of sub-types of TRD and of change. Discussion TRD needs complex, long-term intervention and extended research follow-up for the proper evaluation of treatment outcome. This pushes at the limits of the design of randomised therapeutic trials. We discuss some of the consequent problems and suggest how they may be mitigated. Trial registration Current Controlled Trials ISRCTN40586372 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink